Table 4.
Overall survival | Disease-free survival | ||||
Prognostic factor | Level | Hazard ratio (95% CI) | p value | Hazard ratio (95% CI) | p value |
Basal | CK14-positive | 0.78 (0.56–1.08) | 0.14 | 0.72 (0.52–0.99) | 0.05 |
Age group in years | <35 | 1.0 | 0.0005 | 1.0 | 0.005 |
35–49 | 0.86 (0.54–1.37) | 0.96 (0.60–1.52) | |||
50–64 | 0.77 (0.49–1.22) | 0.80 (0.51–1.26) | |||
65+ | 1.50 (0.91–2.46) | 1.43 (0.87–2.36) | |||
Tumour size | p1 | 1.0 | 0.052 | 1.0 | 0.042 |
p2 | 1.45 (0.84–2.48) | 1.40 (0.83–2.36) | |||
p3 | 1.87 (1.06–3.31) | 1.92 (1.10–3.33) | |||
Lymph node metastasis | Positive | 1.83 (1.42–2.35) | <0.0001 | 1.81 (1.42–2.32) | <0.0001 |
Tumour sizes: p1, <2 cm; p2, 2–5 cm; p3, >5 cm. CI, confidence interval; CK14, cytokeratin 14.